Software may be eating the world, but it was hardware-intensive startups that scooped up this week’s largest funding rounds, ...

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...

SpyGlass Pharma announced today that it closed a $75 million Series D financing round to support its drug delivery platform.

Gland Pharma Q4 Results: Pharma company Gland Pharma on Tuesday, May 20, posted a weak set of numbers for the fourth quarter of the financial year 2024-25 (Q4 FY25), recording a single-digit fall ...

Pharma stocks defy market trend: Dr Reddy’s, Aurobindo, Granules among top gainers as investors turn to defensive bets amid global developments (Image: Canva) Pharma stocks are bucking the ...

Stock Market today: Nifty Pharma index cracked more than 2% in the morning trade on Monday as US President Donald Trump indicated his plans to cut drug prices in the US by 30-80%. Trump on Sunday ...

The Pharma stocks are seeing big cuts in early trade. The Nifty Pharma Index is down over 1% and the BSE Healthcare Index too remains under pressure. Some of the big Nifty losers include the likes ...

Have you ever stopped to think about what happens to those little orange pill bottles after you finish your prescription? Every year, around 200 billion of these bottles are produced worldwide ...

The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.